Close Menu

NEW YORK (360Dx) – Vermillion reported after the close of the market on Tuesday a 24 percent year-over-year rise in first quarter revenues.

For the three months ended March 31, the Austin, Texas-based cancer diagnostics firm said that total revenues rose to $803,000 from $649,000 in the year-ago quarter.

Product revenues were $779,000, up 27 percent from $613,000 in Q1 2018. Service revenues were $24,000, down 33 percent from $36,000 the year before.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.